-
869008-50UG
THYROID STIMULATING HORMONE (C005B-013136)
Price: $544.85List Price: $605.39Native, human growth hormone from pituitary gland. Single chain polypeptide hormone essential for growth of all tissues. -
T341890-1g
trans-4-Hydroxycrotonic acid (C007B-297482)
Price: $9,174.04List Price: $10,193.38trans-4-Hydroxycrotonic acid binds to the γ-hydroxybutyric acid (GHB) receptor with higher affinity than GHB itself. It may be an endogenous ligand. -
T341890-250mg
trans-4-Hydroxycrotonic acid (C007B-297483)
Price: $2,549.10List Price: $2,832.34trans-4-Hydroxycrotonic acid binds to the γ-hydroxybutyric acid (GHB) receptor with higher affinity than GHB itself. It may be an endogenous ligand. -
T341890-50mg
trans-4-Hydroxycrotonic acid (C007B-297484)
Price: $589.74List Price: $655.27trans-4-Hydroxycrotonic acid binds to the γ-hydroxybutyric acid (GHB) receptor with higher affinity than GHB itself. It may be an endogenous ligand. -
3017-10K
TRANSCREENER(TM) EPIGEN METHYLTRANSFERASE ASSAY (C005B-492395)
Price: $14,565.43List Price: $16,183.82TRANSCREENER(TM) EPIGEN METHYLTRANSFERASE ASSAY -
U413785-100mg
UNC0379 (C007B-304829)
Price: $781.91List Price: $868.78InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive -
U413785-10mg
UNC0379 (C007B-304830)
Price: $225.61List Price: $250.68InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive -
U413785-25mg
UNC0379 (C007B-304831)
Price: $431.58List Price: $479.53InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive -
U413785-50mg
UNC0379 (C007B-304832)
Price: $575.05List Price: $638.94InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive -
U413785-5mg
UNC0379 (C007B-304833)
Price: $140.02List Price: $155.58InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive -
U421962-1ml
UNC0379 (C007B-304921)
Price: $333.34List Price: $370.38InformationUNC0379 UNC0379 is a selective, substrate competitive inhibitor of N-lysine methyltransferase SETD8 with IC50 of 7.9 μM, high selectivity over 15 other methyltransferases.TargetsSETD8 (Cell-free assay) 7.3 μMIn vitroUNC0379 is competitive -
V659222-10mg
VT02956 (C007B-432917)
Price: $974.07List Price: $1,082.30VT02956 is a LATS inhibitor ( IC 50 : 0.76 nM for LATS1, 0.52 nM for LATS2). VT02956 targets the Hippo pathway. VT02956 inhibits ESR1 expression and growth of ER+ breast cancer cell lines and patient-derived tumor organoids.IC50&: Target:IC50: